Furosemide Tablet
FDA Label NDC 55154-2349

24 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Furosemide (NDC 55154-2349). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, warning, description, clinical pharmacology, geriatric population, edema, hypertension, contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

NDC 55154-2349-0

FUROSEMIDE TABLETS, USP

20 mg

10 TABLETS

20mg Bag Label (Ee764e1d 0e34 4e02 Bab5 C766786f7663 01)

20mg Bag Label (Ee764e1d 0e34 4e02 Bab5 C766786f7663 01)

NDC 55154-2348-0

FUROSEMIDE TABLETS, USP

40 mg

10 TABLETS

40mg Bag Label (Ee764e1d 0e34 4e02 Bab5 C766786f7663 00)

40mg Bag Label (Ee764e1d 0e34 4e02 Bab5 C766786f7663 00)

* Please review the disclaimer below.